Funding
← Back to your selection

Navigare Ventures

Activity from announced rounds

Activity in this selectionOct 15, 2026 · Biotech · Jul 18, 2026
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$23.1M
2 disclosed · full round size, not this investor’s share

By stage

Series B1
Undisclosed1

By primary sector

Biotech2

By country

Sweden2

Rounds

2 in this selection
EnginZyme

EnginZyme develops cell-free biomanufacturing technology that uses immobilized enzymes to make chemicals and ingredients through scalable industrial processes.

SEK 75MEquity round
Participant
Pixelgen Technologies

High-throughput platform mapping molecular cell architecture at nanoscale resolution

$15.5MSeries B
Role not disclosed